Category Filter
Policies & Guidelines
- Advanced Imaging
- Autism Spectrum Mandate
- Behavioral Health
- Blue Advantage Policies
- Chronic Condition Management
- Genetic Testing
- HelpScript Program
- Hemophilia Drugs
- Medical Oncology Regimen Program
- Medical Policies
- Pharmacy
- Pre-Service Review (Precertification and Predetermination)
- Pre-Service Review (Precertification/Predetermination)
- Pre-Service Review (Predetermination/Precertification)
- Provider-Administered Drug Policies
- Radiation Therapy
- Self-Administered Drug Policies
- Transgender Services
Asset Publisher
Content with Policies & Guidelines Draft Self-Administered Drug Policies .
Abrilada, Actemra, Amjevita, Bimzelx, Cimzia, Cosentyx, Cyltezo, Enbrel, Entyvio, Hadlima, Hulio, Humira, Hyrimoz/Adalimumab-adaz, Idacio, Kevzara, Kineret, Litfulo, Olumiant, Omvoh, Orencia,...
Belbuca, Butrans, Conzip, Duragesic, fentanyl transdermal patch, Hydrocodone ER, hydromorphone ER, Hysingla ER, Kadian, Morphine Sulfate ER, MS Contin, Nucynta ER, Oxycodone ER, OxyContin,...
print
Print
Back
Back
Opioids Immediate Release (IR) Quantity Limit Program Summary
Policy Number: PH-91117...